ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 24, 2025, indicating it will report annual filings under Form 20-F. The event is neutral and not significant from an equity investor perspective.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.